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Trypanosoma cruzi infection induces diverse alterations in immunocompetent cells and organs, myocarditis 
and congestive heart failure. However, the physiological network of disturbances imposed by the infection has not 
been addressed thoroughly. Regarding myocarditis induced by the infection, we observed in our previous work that 
Fas-L-/- mice (gld/gld) have very mild inflammatory infiltration when compared to BALB/c mice. However, all mice 
from both lineages die in the early acute phase. Therefore, in this work we studied the physiological connection re-
lating arterial pressure, renal function/damage and cardiac insufficiency as causes of death. Our results show that 
a broader set of dysfunctions that could be classified as a cardio/anaemic/renal syndrome is more likely responsible 
for cardiac failure and death in both lineages. However, gld/gld mice had very early glomerular deposition of IgM 
and a more intense renal inflammatory response with reduced renal filtration, which is probably responsible for the 
premature death in the absence of significant myocarditis in gld/gld.
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Chagas disease is caused by the protozoan parasite 
Trypanosoma cruzi, which has a widespread distribu-
tion in Latin America. It is estimated that 15-16 million 
people are infected on this continent and 75-90 million 
are exposed to infection (Coura & Dias 2009). Trans-
mission to humans occurs primarily through blood-
sucking reduviid bugs, but it may also occur through 
blood transfusion organ transplant, transplacental trans-
mission and oral infection (Moncayo 2003, Dias et al. 
2008, WHO 2004, Yoshida 2009). The disease is char-
acterised by an initial acute phase and it is generally ac-
cepted that patients with a more severe acute infection 
may develop a more aggressive chronic phase (Higushi 
et al. 2003, Coura 2007). Acute diffuse myocarditis is 
associated with parasite nests and cellular inflamma-
tory foci that are composed of macrophages (Andrade 
1991), CD4+ and mainly CD8+ T cells (Henriques-Pons 
et al. 2002), differentiated as activated/memory T cells 
(CD62LLow, LFA-1High and VLA-4High) (dos Santos et al. 
2001). The chronic phase starts with a usually long-last-
ing indeterminate period, followed by a symptomatic 
dilated myocardiopathy in 25-30% of patients. The cy-
totoxic pathway(s) that destroy cardiomyocytes and the 
precise correlation between inflammatory response and 
heart failure are not known. It is important to evaluate 
which mechanisms regulate cardiac inflammatory pro-
cesses and their interplay with possible causes of death 
from this disease. In our previous work, we observed 
that Fas-L-/- mice (gld/gld) have a very modest cardi-
ac inflammatory response when compared to infected 
BALB/c. Accordingly, we observed less cardiomyo-
cyte death in gld/gld, yet high mortality rates caused by 
unknown reasons (de Oliveira et al. 2007).
Fas-L, a type II membrane homotrimeric protein, be-
longs to the tumour necrosis factor family and triggers 
apoptosis through Fas engagement (Suda et al. 1995). 
However, Fas activation is also involved in the secretion 
of cytokines and chemokines, chemotaxis, genomic tran-
scription, cellular activation and other responses (Lam-
bert et al. 2003). Concerning the infection, it has been 
shown that Fas/Fas-L controls CD4+ T cell population 
through AICD (activation induced cell death) (Lopes et 
al. 1999), parasite replication in vitro (Freire de Lima et 
al. 2000), NO production (Martins et al. 2001) and host 
cytokine response to T. cruzi infection in vivo, prevent-
ing an exacerbated Th2-biased immune response (Lopes 
et al. 1999, Guilhermo et al. 2007). In other pathologies, 
such as Coxsackievirus B3, Fas/Fas-L plays a central role 
in the control of myocarditis, leading cardiac CD4+Th2 
(IL-4+) protective cells to death through the cytotoxic ac-
tivity of σ/δ T cells (Huber et al. 2002, Seko et al. 2002).
Various studies associate Fas/Fas-L with renal in-
sufficiency or failure, possibly through apoptotic events 
not yet completely understood. The most accepted hy-
pothesis for tubular atrophy is based on ischemia in-
duced by apoptosis of tubular epithelial cells mainly 
through Fas/Fas-L interaction. Thus, in chronic renal 
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illness, this ischemic injury promotes intense necro-
sis of many cell types (Bohle et al. 1996, Schelling & 
Cleveland 1999). However, it is well known that human 
patients with chronic renal failure normally present 
with anaemia and congestive cardiac insufficiency. This 
triad named “cardio/anaemic/renal syndrome” (Silver-
berg et al. 2003) creates a vicious circle, where various 
substances, such as angiotensin II, endothelin, reactive 
oxygen species (ROS), epinephrine, erythropoietin and 
tumour necrosis factor, produced by each checkpoint, 
can contribute to renal and cardiac failure (Silverberg et 
al. 2003, Palazzuoli et al. 2008).
Based on our previously observed participation of 
Fas-L in the regulation of acute myocarditis promoted 
by T. cruzi, the main goal of the present study was to 
evaluate the influence of this molecule in the death of 
mice (gld/gld and BALB/c), targeting more systemic 
possible dysfunctions. We observed similar disturban- 
ces in both mouse lineages and concluded that Fas-L is 
not a central molecule in the regulation of a cardio/anae-
mic/renal syndrome. However, the lack of Fas-L pro-
motes more severe renal lesions, worsening the course 
of the infection and probably leading glg/gld to death 
despite moderate myocarditis.
MATERIALS AND METHODS
Mice - Seven-week old specific pathogen-free male 
gld/gld mice and their counterpart isogenic BALB/c 
were obtained from the Fiocruz animal facility. Mice 
were housed for at least one week before parasite infec-
tion at the Animal Experimentation Division of the Cel-
lular Biology Laboratory-Fiocruz under environmental 
factors and sanitation conforming to the Guide for the 
Care and Use of Laboratory Animals [DHEW Publica-
tion (NIH) 80-23, revised 1985]. This project has pro-
tocol 0099/01 at the Fiocruz Committee of Ethical in 
Research, according to resolution 196/96 of the National 
Health Council of the Brazilian Ministry of Health. The 
number of animals used in each experiment is depicted 
in figure legends.
Parasites and infection - T. cruzi Y strain was 
maintained by in vivo passages in non-syngeneic Swiss 
Webster mice and blood trypomastigote forms were 
isolated as previously described (Araújo-Jorge 1989). 
Parasites were then diluted in saline and counted in a 
haemocytometer to adjust the inocula to 1 x 103 para-
sites/200 µL for intraperitoneal (i.p.) injection. Some 
dosages and analysis were done on alternate days post 
infection (dpi), as indicated in graphs, to avoid exces-
sive manipulation of mice.
Histopathological analysis - Mice were euthanised 
on dpi zero, 8 and 15 to collect hepatic and renal tissues 
to be processed as described elsewhere (Andrade 1990). 
Briefly, fragments were fixed using Millonnig-Rosman 
solution (Araújo-Jorge 2000) and 5 µm-thick slices of 
paraffin embedded samples were further processed and 
stained with H&E. Qualitative analysis of tissues was 
based on general appearance and tissue architecture, pa-
renchyma and endothelial cell integrity, glomerular and 
tubular preservation, edema, cellular inflammatory in-
filtration and parasite nests.
Anti-IgM labelling was carried out using renal tissue 
slices of cryopreserved TissueTec-embedded (Sakura, 
CA, USA) kidneys. Endogenous peroxidase activity 
was blocked with a solution of 3% hydrogen peroxide in 
phosphate buffered saline (PBS - Sigma) for 5 min. Sec-
tions were then rinsed for 20 min in PBS and incubated 
for 20 min with inactivated normal sheep serum (10% in 
PBS) to block Fcγ receptors. To identify glomerular IgM 
deposition, we used a peroxidase-conjugated rat IgG anti 
mouse IgM mAb (Southern, Birmingham, AL) incubat-
ed for 3 h at RT in a moist chamber. Slides were then 
rinsed with PBS for 15 min and enzyme activity was 
detected with 3,3’-diaminobenzidine in chromogen so-
lution (Dako Cytomation, Denmark) and counterstained 
with Mayer’s haematoxylin for 1 min.
Non invasive parameters
Urinalysis - Before the collection of urine samples, 
mice were adapted for one week (2 h/day) to individual 
metabolic boxes for sample collection. The urine from 
control and infected mice was collected on dpi zero, 6, 
15 and 20 and immediately analyzed for bilirubin, uro-
bilinogen, ketones, glucose, total protein, blood, nitrite, 
specific gravity (density), pH and leukocytes (Kit for 
reacting band system for semi quantitative determina-
tion - Uriquest® - Lab Test Diagnóstica, Rio de Janeiro 
- Brazil). In addition, the time lag for the first urination 
and urine volume were individually registered.
Blood analysis - Serum levels of urea (URE) and CREA 
(CREA) - We evaluated serum levels of URE and CREA as 
indicators of renal function in blood samples collected from 
tail snips on dpi zero, 6, 15 and 20. Ten microliters of serum 
were collected and diluted in 1 mL of bovine serum albu-
min 7% to evaluate each parameter, in accordance with the 
manufacturer, using VITROS® 750XRC Chemistry Ana-
lyzer (Ortho-Clinical Diagnostics - Rochester, NY).
Blood pressure - Before evaluation of blood pressure, 
mice were adapted daily for seven days and a tail sphyg-
momanometer was fitted for three consecutive readings 
until stabilisation. Blood pressure was individually re-
corded on dpi zero, 6, 9 and 15 using an LE 5001 Pressure 
meter® (PanLab Instruments, Barcelona - Spain), evalu-
ating caudal artery pressure in non-sedated animals. Val-
ues of systolic, diastolic (DP) and the mean pressure were 
calculated as indicated by the manufacturer.
Echocardiographic studies - Echocardiograph analy-
ses were performed using a 2-dimensional echo Doppler 
cardiogram (Esaote, model CarisPlus, Firenze-Italy). 
The standard parasternal long and short axis views were 
obtained with a 10 MHz transducer and all animals were 
i.p. tranquilised with diazepan (20 mg/kg body weight) 
(Compaz® - Cristália Inc, Rio de Janeiro - Brazil). The 
following parameters were acquired according to the 
American Society of Echocardiography: diameter of the 
left ventricle in diastole and systole, septal and posterior 
wall thickness, shortening fraction (SF), left ventricular 
ejection fraction and aortic valve area (AVA) at M-mode 
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and B-mode. Isovolumetric relaxation time, peak early 
(E) and late DP transmitral flow velocities, E decelera-
tion time, ejection time (ET), maximal aortic velocity 
and flow velocity integral of aortic flow (FVI) were 
obtained using Echo Doppler. Cardiac output (CO) was 
obtained from the product of the FVI by AVA.
Electrocardiographic studies - All mice were i.p. 
tranquilised with diazepan (20 mg/kg) and transducers 
were carefully placed under the skin in accordance with 
chosen preferential derivation (DII). Traces were record-
ed using a digital system (Power Lab 2/20) connected 
to a bio-amplifier in 2 mV for 1s (PanLab Instruments). 
Filters were standardised between 0,1 and 100 Hz and 
traces were analyzed using the Scope software for Win-
dows V3.6.10 (PanLab Instruments). We measured heart 
rate (beats/min-bpm), duration of the PR, QRS, QT in-
tervals and P wave in ms (millisecond) on dpi zero, 8, 
15 and 22. The relationship between the QT interval and 
RR interval was individually assessed. To obtain physi-
ologically relevant values for the heart rate-corrected 
QT interval (QTc), in units of time rather than time to a 
power not equal to 1, the observed RR interval (RR0) was 
first expressed as a unitless multiple of 100 ms, giving 
a normalised RR interval (RR100 = RR0/100 ms). Next, 
the value of the exponent (y) in the formula QT0 = QTc x 
RRy100 was assessed, where QT0 is the observed QT and 
both QT and QTc are in milliseconds. Taking the natural 
logarithm of each side of the formula (QT0) = In (QTc) + 
yln(RR100), the slope of the linear relationship between 
the log-transformed QT and RR100 thus defined the ex-
ponent to which the RR interval ratio should be raised to 
correct QT for heart rate (Mitchell et al. 1998).
Haematology - Red blood series were evaluated on 
dpi zero, 6 and 13 by directly counting the number of 
erythrocytes per mL (red blood count - RBC) using a 
Neubauer chamber with 20 µL of blood diluted in 4 mL 
of PBS. For haematocrit determination (globular vol-
ume - %), we collected 50 µL of blood using heparinised 
micro capillaries and centrifuged for 5 min at RT. Data 
are expressed as percentages and were measured using 
a specific ruler. Haemoglobin was determined based on 
free haemoglobin levels using a colorimetric assay as 
follows. Briefly, 250 µL of the working reagent (Hemo-
globina®, Lab Test Diagnóstica, Rio de Janeiro - Brazil) 
were added to 10 µL of freshly collected blood, then the 
solution was incubated for 5 min at 37oC and thereafter 
the optical density (absorbance) was determined using 
a spectrophotometer (540 nm) (VersaMax®, Molecular 
Devices, Sunnyvale - CA) as recommended by the man-
ufacturer. The concentration of haemoglobin globular 
average (CHGM - %) was calculated according to the 
formula: haemoglobin dosage/globular volume. There-
fore, whenever observed, anaemia was classified as hy-
pochromic or normochromic.
Captopril and erythropoietin treatment
BALB/c and gld/gld mice received captopril (5 mg/L, 
Ranbaxy Pharmaceuticals, Rio de Janeiro - Brazil) in 
their drinking water ad libitum from day -1 of infection 
until death. The captopril solution was changed three 
times a week and freshly prepared from powder every 
time. For erythropoietin treatment, both mouse lineages 
received human recombinant erythropoietin (Dragon 
Pharmaceuticals, Vancouver, Canada) diluted in saline 
(0,9%) at a dose of 1.500 U/Kg (200 μL of i.p. injections 
3 times/week). Parasitaemia, expressed as parasites/mL, 
was evaluated in 5 µL of blood collected from tail snips 
at the indicated time points (Araújo-Jorge 2000).
Statistical analysis - The Mann-Whitney non para-
metric test was used to compare two sets of data (Soft-
ware SPSS version 8.0) and p values are indicated in 
figure legends.
RESULTS
Renal filtration and damage - As cardiac function 
may also be affected by liquid retention due to decreased 
renal filtration, we initially measured the urine volume 
in acutely infected mice (Fig. 1A, B). Our results showed 
that control BALB/c mice urinated a greater volume (280 
µL) (Fig. 1A) than gld/gld mice (130 µL) before infection 
and on dpi 6 (Fig. 1B). Regarding urine urobilinogen 
(Fig. 1C, D), we observed a significant increase in in-
fected BALB/c only on dpi 15, but in gld/gld mice it was 
already increased on dpi 6. Urine leukocyte evaluation 
(Fig. 1E, F) suggested renal damage in both lineages, 
but it was also detected earlier in gld/gld (dpi 6), when 
compared to BALB/c (dpi 15). Other parameters such as 
bilirubin, ketones, glucose, protein, blood, nitrite, spe-
cific gravity (density) and pH showed no significant dif-
ferences between both lineages (data not shown).
Renal function - Renal function was evaluated by 
measuring URE, CREA, Na+ and K+ in blood and both 
lineages showed similar levels of all parameters before 
infection (Fig. 2), indicating no relevant natural renal 
dysfunction in gld/gld. However, BALB/c and gld/gld 
showed significantly higher levels of URE from dpi 6 
on, although gld/gld was more affected (Fig. 2A, B). As 
with URE, serum levels of CREA increased after dpi 6, 
but only at this time point were the levels higher in gld/
gld (Fig. 2C, D). Regarding blood electrolytes (Na+ and 
K+), no significant differences were observed between 
both lineages (data nor shown).
Renal damage - Histopathological analysis of control 
mice from both lineages showed preserved renal tissue 
(Fig. 3A, B). However, BALB/c mice on dpi 6 showed 
discrete damage of proximal tubules and glomerular 
atrophy (Fig. 3C). Gld/gld mice showed similar altera-
tions, but with a more pronounced outcome associated 
with a modest inflammatory infiltration (Fig. 3D). On 
dpi 15, BALB/c mice presented with glomerular atrophy 
and apparent necrosis, with discrete glomerular haemor-
rhage and cellular degeneration near proximal tubules 
(Fig. 3E). Interestingly, gld/gld mice presented with an 
intense cellular inflammatory infiltration, necrotic de-
generation (Fig. 3F), glomerular atrophy and haemor-
rhage (Fig. 3F, detail). We observed no parasite nests in 
either group (data not shown).
Cardiovascular function - Both lineages presented 
similar values of mean arterial pressure before infection, 
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but on dpi 6 BALB/c (Fig. 4A) and gld/gld mice (Fig. 
4B) showed a significant decrease in blood pressure (hy-
potension peak). On the other hand, on dpi 15 the arte-
rial pressure increased to above basal levels in BALB/c, 
whereas this happened from dpi 9 on in gld/gld, with a 
hypertension peak on dpi 9 (Fig. 4B).
Among all parameters evaluated by echocardiography 
(Table I) (Materials and Methods), no alterations were ob-
served in control mice from either lineage, indicating no 
relevant natural cardiac dysfunction in gld/gld. However, on 
dpi 7 infected BALB/c showed abnormal cardiac function, 
as ascertained by altered values of LV(s), septum (s), ejection 
fraction, SF and ejection time. In addition, on dpi 14 these 
parameters had worsened and there were alterations in LV 
(d), left atrium and Ao/AE (relation between left atrium and 
aortic base), indicating the decline of cardiac function (Ta-
ble I). Gld/gld showed basically the same pattern of cardiac 
alterations, although apparently more severe and established 
earlier when compared to BALB/c, especially regarding LV 
(d) and (s) and ET parameters (Table I).
Cardiac electric conduction system - Once more we 
found comparable and normal data regarding cardiac 
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Fig. 1: urine evaluation. BALB/c (left panels, ■) and Fas-L-/- mice 
(gld/gld) (right panels, ▲) were individually contained for urine 
collection and we evaluated: urine volume (A, B), urobilinogen (C, 
D) and leukocyte number (E, F) at indicated time-points. Dashed 
line indicates maximal time of experiment (E, F). Asterisks in-
dicate statistical difference when infected mice are compared to 
control mice of the same lineage (p < 0.05). Data are representative 
of three experiments with 5-10 mice each. #: significant difference 
when BALB/c and gld/gld mice are compared at the same time-
point (p < 0.05).
Fig. 2: acute renal insufficiency. Serum levels of urea (URE) and creati-
nine (CREA) were evaluated as indicators of renal failure. Blood samples 
were collected at indicated time-points from BALB/c (left panels, ■) and 
Fas-L-/- mice (gld/gld) (right panels, ▲) mice. Asterisks indicates statisti-
cal difference when infected mice are compared to control mice of the 
same lineage (p < 0.05). Data are representative of three experiments with 
10 mice each. #: significant difference when BALB/c and gld/gld mice are 
compared at the same time-point (p < 0.05).
Fig. 3: renal histopathological analysis. BALB/c (left panels) and Fas-
L-/- mice (gld/gld) (right panels) were euthanized on zero (A, B), 8 
(C, D) and 15 (E, F) days post infection with T. cruzi. Kidneys were 
collected for further paraffin-embedded processing and stained with 
H&E. Arrows indicate proximal tubule destruction and arrowheads 
indicate cellular inflammatory infiltration (400X). Insert shows 
glomerular atrophy in gld/gld mice (1000X). Data are representative 
of three experiments with 10 mice each.
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function in both lineages before infection, now based on 
ECG analysis (Table II). Besides this, a greater differ-
ence was observed in the heart rate, which was reduced 
until dpi 22 in both lineages, but again the alteration was 
earlier and more pronounced in gld/gld (Table II). Only 
the QTc interval showed a significant increase on dpi 15 
in BALB/c mice and on dpi 22 in both lineages and in 
gld/gld we detected a sinusal bradycardia and discrete 
sinusal arrhythmia (data not shown).
Red cell evaluation - There was a significant de-
crease in RBC, globular volume and haemoglobin levels 
on dpi 13 in both groups (Fig. 5A-F) (murine reference 
values: RBC = 8.7 x 106/mL, Hct = 44%, Haemoglobin = 
12.2 gm/dL) (27). Besides this, CHGM was around 23% 
in both lineages on dpi 13 (standard value 25.3%) (data 
not shown) (Fox et al. 1984). These haematological dis-
turbances, hypochromic and normocitic anaemia, could 
also be playing a role in the cardiac insufficiency and 
maybe worsening the multiple and systemic alterations 
that were observed, especially in gld/gld. Moreover, hy-
pochromic and normocitic anaemia are usually associ-
ated with renal deficit (Silverberg et al. 2005).
Renal lesions and cardiac failure - We evaluated 
whether IgM deposits could play a role in renal damage 
and, therefore, in renal dysfunction. We observed no 
relevant IgM labelling in control (Fig. 6A) or infected 
BALB/c mice on dpi 6 (Fig. 6B). However, on dpi 15 
we observed tissue labelling apparently in the mesan-
gial area (Fig. 6C). Before infection, gld/gld mice pre-
sented moderate glomerular IgM deposits (Fig. 6D) and 
this is possibly a result of many pre-existing immune 
alterations observed in these mice, such as high levels 
of auto-immune Igs (Boes et al. 2000). This precipita-
tion increased and a higher glomerular labelling of IgM 
was observed very early in infected gld/gld mice (dpi 6) 
(Fig. 6E). However, there was a decrease in the labelling 
on dpi 15 (Fig. 6F).
To evaluate the relevance of angiotensin convert-
ing enzyme (ACE) and cardiac function on mortality, 
BALB/c and gld/gld mice were treated daily with cap-
topril, starting before infection (day-1) as a potential 
preventive treatment for cardiac and renal dysfunction. 
Captopril binds to the ACE and inhibits ACE’s catalytic 
production of angiotensin II (Leon et al. 2003). Capto-
pril had no effect on parasitaemia of BALB/c or gld/
gld mice (Fig. 6G). However, this treatment postponed 
and reduced BALB/c mortality and had no influence on 
gld/gld death (Fig. 6H).
DISCUSSION
Previous results from our group showed that in the 
absence of the perforin-dependent cytotoxic pathways, 
the severity of acute myocarditis is increased after T. 
cruzi infection (Henriques-Pons et al. 2002). We there-
fore decided to examine whether the Fas-L-dependent 
pathway would also influence the evolution of myo-
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Fig. 4: arterial pressure. Blood arterial pressure was evaluated with a 
tail sphygmomanometer in non-tranquilized mice. BALB/c (A) and 
Fas-L-/- mice (gld/gld) (B) were previously adapted and stabilized read-
ings were recorded at indicated time-points. Asterisks indicate statisti-
cal difference when infected mice are compared to control mice of the 
same lineage (p < 0.05). Data represent three experiments with at least 
eight mice. #: significant difference when BALB/c and gld/gld mice are 
compared at the same time-point (p < 0.05).
TABLE I
Echocardiographic studies
dpi 0 7 14
Lineage
BALB/c
n = 10
gld/gld
n = 10
BALB/c
n = 10
gld/gld
n = 10
BALB/c
n = 7
gld/gld
n = 5
LVd (mm) 0.27 ± 0.03 0.27 ± 0.03 0.28 ± 0.02 0.4 ± 0.08a,b 0.36 ± 0.05a 0.36 ± 0.06a
LV (s) 0.11 ± 0.01 0.13 ± 0.04 0.21 ± 0.02a 0.33 ± 0.1a,b 0.28 ± 0.05a 0.32 ± 0.0a
Septum (d) 0.07 ± 0.01 0.07 ± 0.01 0.06 ± 0.0 0.06 ± 0.0 0.06 ± 0.0 0.06 ± 0.0
Septum (s) 0.13 ± 0.03 0.12 ± 0.01 0.07 ± 0.01a 0.09 ± 0.02a 0.08 ± 0.01a 0.07 ± 0.01a
Left atrium 0.12 ± 0.01 0.13 ± 0.02 0.13 ± 0.01 0.14 ± 0.03 0.16 ± 0.01a 0.22 ± 0.0a
Ao/AE 1 ± 0.1 1 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.7 ± 0.1a 0.6 ± 0.1a
Ejec. Fraction (%) 91.3 ± 3.2 86.4 ± 8.5 58 ± 10.1a 58 ±1 0.1a 42.9 ± 20.4a 47.9 ± 11.0a 30.6 ± 5.7a,b
Short. Fraction (%) 57.6 ± 4.9 51.9 ± 11.8 26 ± 5.3a 18.6 ± 12.0 20.7 ± 5.0a 12 ± 3.1a,b
Ejec. Time (ms) 67.4 ± 5.1 71 ± 9.2 54.7 ± 5.9a 63.4 ± 3.2a,b 47.6 ± 10.4a 54 ± 1.0a
values are means ± SD. AE: left atrium; Ao: aortic base; d: diastole; gld/gld: Fas-L-/- mice; LV: left ventricle; s: systole. a: when comparing in-
fected mice to control mice of the same lineage (p < 0,05); b: when comparing BALB/c and gld/gld mice on the same time-point (p < 0,05).
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carditis after infection and observed that in gld/gld mice 
there is a very mild cardiac inflammation, but a high 
mortality rate (de Oliveira et al. 2007). There are few 
studies addressing the Fas-L relevance in T. cruzi infec-
tion, such as in: (i) atrophy of mesenteric lymph nodes 
(de Meis et al. 2006) and thymus (Henriques-Pons et al. 
2004), (ii) NO production and apoptosis in splenocytes 
(Martins et al. 1999) and (iii) control of Th1/Th2 bal-
ance (Lopes et al. 1999). Recent publications report that 
a Th2-biased immune response with higher levels of IL-
10 and IL-4 in gld/gld is associated with increased sus-
ceptibility to experimental infection (Guilhermo et al. 
2007), although it might be different in human patients 
(Araújo et al. 2007). It is possible that T. cruzi-infected 
gld/gld mice are more susceptible to the infection due to 
a complex array of pre-existing and infection-imposed 
systemic alterations, including components of the im-
mune system and organ dysfunction.
In agreement with our results regarding myocardi-
tis in infected gld/gld mice, it was published that cox-
sackievirus B3-induced myocarditis is also decreased 
in the absence of Fas/Fas-L interaction (Seko et al. 
2002). However, after T. cruzi infection all gld/gld died 
in the early acute phase, suggesting that other disturb- 
ances can occur and lead gld/gld to death. Thus, the 
goal of the present study was to investigate the partici-
pation of FasL in the possible systemic alterations, oth-
er than myocarditis, that could be related to the death 
of T. cruzi infected mice. To date, human patients with 
anaemia and chronic renal failure have more severe 
cardiac insufficiency (Silverberg et al. 2003). More-
over, anaemia is found in about one third of all cases 
of congestive heart failure (CHF) and is the most likely 
common cause of chronic renal insufficiency, which is 
present in about half of all CHF cases (Silverberg et al. 
2004). The authors considered and discussed the exist- 
ence of a complex feedback known as cardio/anaemic/
renal syndrome (Silverberg et al. 2003). In the present 
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Fig. 5: blood red series evaluation. Blood was collected from tail tips 
from BALB/c (left panels, ■) and Fas-L-/- mice (gld/gld) (right panels, 
♦) mice at indicated time-points to evaluate erythrocyte number (A, 
B), globular volume (C, D) and hemoglobin concentration (E, F). Data 
are representative of three experiments with 10 mice each. Asterisks 
indicate statistical difference when infected mice are compared to 
control mice of the same lineage (p < 0.05).
Fig. 6: mechanisms leading to renal damage/dysfunction and cardiac 
failure. We collected kidneys from BALB/c (A-C) and Fas-L-/- mice (gld/
gld) (D-F) before infection (A-D), on 6 (B, E) and 15 (C, F) days post 
infection (dpi). Tissue slices were labeled with anti-IgM mAb and glo- 
merular deposits were identified with HPR activity. Parasitemia (G) and 
mortality rate (H) are shown in captopril-treated BALB/c (BALB/c cap 
▲, solid line), captopril-treated gld/gld (gld/gld cap Δ, solid line), both 
from dpi -1 of infection. ■, dashed line: untreated infected BALB/c; □, 
dashed line: untreated gld/gld. Bar = 20 μm.
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paper we observed a decrease in haemoglobin concen-
tration on dpi 6 and this anaemia could therefore ag-
gravate renal damage and cardiac insufficiency during 
infection in both lineages, although worsened in gld/
gld. Therefore, we treated in vivo with recombinant 
erythropoietin, since it has been used in the treatment 
of anaemia associated with renal failure, leading to 
the improvement of cardiac function (Silverberg et al. 
2005). However, we observed no reversion in the mor-
tality rate of either mouse lineage after treatment (un-
published observations), thus suggesting that anaemia 
does not directly lead mice to death, but it may play a 
role when combined with other dysfunctions.
Our results showed an increase in URE and CREA, 
oliguria and even anuria in mice from both lineages, 
clearly indicating renal dysfunction (Nelson & Couto 
1992). Moreover, histopathological analysis showed 
glomerular IgM deposits (we found no IgG precipitates) 
(data not shown), possibly leading to complement ac-
tivation, renal damage and acute kidney injury (AKI) 
(Thadhani et al. 1996). However, additional pathophysi-
ological alterations could be taking place, such as com-
pensatory neuronal-endocrine mechanisms, leading to 
tissue damage. We do not know why infected gld/gld 
have earlier renal IgM deposits, but these deposits may 
be induced by a combination of pre-existing alterations 
of the innate immune system of these mice and the in-
fection, favouring the precipitation of polyreactive IgM 
molecules on dpi 6. Moreover, we observed degenera-
tion of proximal tubules, perivascular edema and inter-
stitial congestion in both groups of mice. On dpi 15 we 
observed the aggravation of tubular damage in gld/gld 
and intense inflammatory infiltration.
AKI may have several causes: inflammatory infil-
tration, endothelial damage, ROS increase, production 
of nitrogen species and other mediators of tubular cells’ 
sub-lethal or lethal damage (Boneventre & Zuka 2004, 
Friedewald & Rabb 2004). After necrotic death, many 
pro-inflammatory mediators are released, culminating 
in the recruitment of blood leukocytes and cellular ac-
tivation/function (Cines et al. 1988). Fas/Fas-L interac-
tion plays an important role in these steps (Kataoka et al. 
2000, Thone & Tschopp 2001) and also in apoptosis.
TABLE II
Eletrocardiographic studies
dpi 0 8 15 22
Mouse lineage BALB/c gld/gld BALB/c gld/gld BALB/c gld/gld BALB/c gld/gld
P (ms) 8.5 ± 1.2 10.0 ± 2.4 10.7 ± 3 11.6 ± 1.5 9.7 ± 1.7 9.7 ± 2.9 13.5 ± 1.9 13 ± 2
PR 31.7 ± 4.1 33.5  ± 4 36.5 ± 4.2 36 ± 7.2 34.7 ± 5.3 36 ± 2.5 33 ± 13.2 37 ± 4
QRS 8.5 ± 1.7 8.7 ± 0.7 9.6 ± 1.1 9.2 ± 1.2 7.7 ± 1.5 9.2 ± 1.2 11 ± 1.6 11 ± 1
QTc 20 ± 3.2 18.7 ± 4.8 19.9 ± 6.7 19.9 ± 2.4 29.5 ± 1.1a 24.8 ± 5.5 29.8 ± 4.4a 35.3 ± 4.4a
Heart rate (bpm) 534 ± 14.1 479 ± 7.1 500 ± 9.5 430 ± 18.8b 446 ± 9.1a 395 ± 11a,b 414 ± 18.9a 195 ± 95.4a,b
values are means ± SD. a: when comparing infected mice to control mice of the same lineage (p < 0,05); b: when comparing 
BALB/c and Fas-L-/- mice (gld/gld) on the same time-point (p < 0,05); dpi: days post infection.
We do not know yet why gld/gld mice have a higher 
renal inflammatory response but more moderate myo-
carditis, when compared to BALB/c (de Oliveira et al. 
2007). Fewer cells migrate to the cardiac tissue of gld/
gld, but in both lineages we found a cardiac CD4/CD8 
double negative T cell population. However, only these 
cells collected from gld/gld had a phenotype that sug-
gested attenuation of cellular effector functions (de Oli- 
veira et al. 2007). These findings illustrate the complex-
ity of the roles played by Fas/Fas-L in the regulation of 
the inflammatory response in different organs during 
infection. On the other hand, our data regarding a cardio/
anaemic/renal syndrome indicate that both lineages have 
similar physiological and general alterations, but with an 
earlier and worse outcome in gld/gld. For example, arte-
rial hypotension is observed on dpi 6 in both infected 
lineages, with high levels of CREA. Hypotension and 
shock are common events in critically ill patients, lead-
ing to AKI and renal failure that may promote accumula-
tion of toxic substances, vasoplegia and finally hypoten-
sion. Moreover, moderate hyperchloraemic acidosis may 
promote vasodilatation and thus lower blood pressure, 
impairment of CO and decreased perfusion in both liver 
and kidneys, probably through down-regulation of Beta-
2 receptors (Hoste & Kellun 2006).
We observed very early signs of cardiac insufficien-
cy, such as a reduction of contraction capacity and ejec-
tion fraction and it is reasonable to hypothesise that renal 
damage is involved in heart failure through the activa-
tion of the renin-angiotensin system (RAS), for example. 
Most of the well-known cardiovascular and renal effects 
of RAS are attributed to ACE, but less is known about 
its function in the cardiac muscle itself. Functional an-
giotensin II receptors have been documented in cardiac 
fibroblasts as well as an intracardiac effect induced by 
short and long-term aldosterone stimulus (Linjnem & 
Petrov 2003). In vitro, angiotensin II increases cardiac 
fibroblast-mediated collagen synthesis and mRNA levels 
of collagen type I, type III, pro-alpha1 (I) collagen, pro-
alpha1 (III) collagen and fibronectin, as well as inhib-
ited matrix metalloproteinase I activity. The angiotensin 
II-dependent secretion and expression of collagen was 
completely abolished by AT1 receptor antagonism, but 
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not by AT2 antagonists (Linjnem & Petrov 2003). More-
over, in kidneys, ACE2 protein levels were significantly 
decreased in hypertensive rats, suggesting a negative 
regulatory role of ACE2 in blood pressure control (Da-
nylczyk & Penninger 2006). We observed in the pres-
ent paper that captopril treatment postponed BALB/c 
mortality but had no effect on gld/gld death. This may 
be interpreted by at least two not mutually exclusive al-
ternatives: (i) pre-existing alterations predisposed gld/
gld mice to very early and important renal damage that 
was not sufficiently reverted by captopril and/or (ii) al-
though BALB/c and gld/gld apparently present the same 
sequence of central events, certain checkpoints may be 
more directly related to death in either lineage. Beyond 
the renal target of ACE activity, captopril acts to a certain 
extent reducing systemic arterial pressure, peripheral 
vascular resistance, cardiac filling pressure and increas-
ing CO. Although captopril is also an anti-inflammatory 
agent, no alteration in T-cell proliferative response to T. 
cruzi or in the levels of T. cruzi and myosin-specific IgG 
was observed (Leon et al. 2003). Moreover, captopril 
upregulates bradykinin, leading to nitric oxide synthesis 
(Anning et al. 1997, Gallagher et al. 1998), which may 
be important in the resistance to acute T cruzi-induced 
myocarditis. It is also important to observe that captopril 
reduces cardiac necrosis and fibrosis in T. cruzi infected 
mice (Danylczyk & Penninger 2006).
In summary, mice infected with T. cruzi develop a 
cardio/anaemic/renal syndrome in the acute phase and 
our observations indicate antagonistic Fas-L-based im-
munoregulatory functions in heart and kidney. In the ab-
sence of Fas-L, there is minor myocarditis but a higher 
renal inflammatory response and damage (de Oliveira et 
al. 2007), possibly due to earlier renal IgM deposits. This 
renal dysfunction would, in turn, increase negative effects 
induced by the infection in the cardiovascular system, af-
fecting blood pressure and cardiac dysfunction, for ex-
ample. Considering the anaemia, these alterations would 
lead to a cycle that could be responsible for the death of 
the mice. However, although BALB/c mice experience 
similar cardiac/renal alterations (damage/insufficiency), 
these events occur later in the infection, are less intense 
and can be partially reverted by captopril treatment.
ACkNOwLEDGEMENTS
To Mr. Luis Lopes Carvalho, for invaluable assistance in 
the pathological analysis, and to Dr. Alejandro Marcel Has-
slocher Moreno, for important suggestions.
REFERENCES
Andrade SG 1990. Influence of Trypanosoma cruzi strain on the 
pathogenesis of chronic myocardiopathy in mice. Mem Inst 
Oswaldo Cruz 85: 17-27.
Andrade ZA 1991. Pathogenesis of Chagas’ disease. Res Immunol 
142: 126-129.
Anning PB, Grocott-Mason RM, Lewis MJ 1997. Effects of sulphy-
dryl and non-sulphydryl-containing ACE inhibitors on left ven-
tricular relaxation in the isolated guinea pig heart. Endothelium 
5: 265-275.
Araujo FF, Gomes JA, Rocha MO, Williams-Blangero S, Pinheiro 
VM, Morato MJ, Correa-Oliveira R 2007. Potential role of 
CD4+CD25HIGH regulatory T cells in morbidity in Chagas dis-
ease. Front Biosci 1: 2797-2806.
Araújo-Jorge TC 1989. The biology of Trypanosoma cruzi-mac-
rophage interaction. Mem Inst Oswaldo Cruz 84: 441-462.
Araújo-Jorge TC 2000. Doença de Chagas: manual para experimen-
tação animal, Editora Fiocruz/Instituto Oswaldo Cruz, Rio de 
Janeiro, 368 pp.
Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein 
A, Chen J 2000. Accelerated development of IgG auto-antibodies 
and autoimmune disease in the absence of secreted IgM. Proc 
Natl Acad Sci USA 97: 1184-1189.
Bohle A, Muller GA, Wehrmann M, Mackensen-Haen S, Xiao JC 
1996. Pathogenesis of chronic renal failure in the primary glo- 
merulopathies, renal vasculopathies and chronic interstitial ne-
phritides. Kidney Int 54 (Suppl.): S2-9.
Boneventre JV, Zuka A 2004. Ischemic acute renal failure: an inflam-
matory disease? Kydney Int 1: 480-485. 
Cines DB, Pollak ES, Buck CQ, Loscalzo J, Zimmerman GA, McEv-
er RP, Pober JS, Wick J, Konkle BA, Stern DM 1988. Endothe-
lial cells in physiology and pathophisiology of vascular disorders. 
Blood 2: 3527-3534.
Coura JR 2007. Chagas disease: what is known and what is needed-a 
background article. Mem Inst Oswaldo Cruz 102 (Suppl. I): 113-122.
Coura JR, Dias JCP 2009. Epidemiology, control and surveillance of 
Chagas disease: 100 years after its discovery. Mem Inst Oswaldo 
Cruz 104 (Suppl. I): 31-40.
Danilczyk U, Penninger JM 2006. Angiotensin-converting enzyme II 
in the heart and the kidney. Circ Res 98: 463-471.
De Meis J, Mendes-da-Cruz DA, Farias de Oliveira DA, Correa-de-
Santana E, Pinto-Mariz F, Cotta-de-Almeida V, Bonomo A, Savi-
no W 2006. Atrophy of mesenteric lymph nodes in experimental 
Chagas’ disease: differential role of Fas/Fas-L and TNFRI/TNF 
pathways. Microbes Infect 8: 221-231.
de Oliveira GM, Diniz RL, Batista W, Batista MM, Bani Correa C, de 
Araujo-Jorge TC, Henriques-Pons A 2007. Fas ligand-dependent 
inflammatory regulation in acute myocarditis induced by Try-
panosoma cruzi infection. Am J Pathol 171: 79-86.
Dias JP, Bastos C, Araújo E, Mascarenhas AV, Martins Netto E, Gras-
si F, Silva M, Tatto E, Mendonça J, Araújo RF, Shikanai-Yasuda 
MA, Aras R 2008. Acute Chagas disease outbreak associated 
with oral transmission. Rev Soc Bras Med Trop 41: 296-300.
dos Santos PV, Roffê E, Santiago HC, Torres RA, Marino AP, Paiva 
CN, Silva AA, Gazzinelli RT, Lannes-Vieira J 2001. Prevalence 
of CD8(+)alpha beta T cells in Trypanosoma cruzi-elicited myo-
carditis is associated with acquisition of CD62L(low)LFA-1(high)
VLA-4(high) activation phenotype and expression of IFN-gamma-
inducible adhesion and chemoattractant molecules. Microbes In-
fect 3: 971-984.
Fox GJ, Cohen JB, Loew MF 1984. Laboratory animal medicine, Aca-
demic Press Inc, Harcout Brace Jovanovich Publishers, San Diego, 
1265 pp.
Freire de Lima CG, Nascimento DO, Soares MB, Bozza PT, Castro-
Faria-Neto HC, de Mello FG, DosReis GA, Lopes MF 2000. Up-
take of apoptotic cells drives the growth of a pathogenic trypano-
some in macrophages. Nature 403: 199-203.
Friedewald JJ, Rabb H 2004. Inflamatory cells in ischemic acute renal 
failure. Kydney Int 66: 486-491.
Gallagher AM, Yu H, Printz MP 1998. Bradykinin-induced reduc-
tions in collagen gene expression involve prostacyclin. Hyperten-
sion 32: 84-88.
1071Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 104(8), December 2009
Guillermo LV, Silva EM, Ribeiro-Gomes FL, De Meis J, Pereira WF, 
Yagita H, DosReis GA, Lopes MF 2007. The Fas death pathway 
controls coordinated expansions of type 1 CD8 and type 2 CD4 T 
cells in Trypanosoma cruzi infection. J Leukoc Biol 81: 942-951.
Henriques-Pons A, De Meis J, Cotta-De Almeida V, Savino W, 
Araújo-Jorge TC 2004. Fas and perforin are not required for 
thymus atrophy induced by Trypanosoma cruzi infection. Exp 
Parasitol 107: 1-4.
Henriques-Pons A, Oliveira GM, Paiva MM, Correa AF, Batista 
MM, Bisaggio RC, Liu CC, Cotta-de-Almeida V, Coutinho CM, 
Persechini PM, Araújo-Jorge TC 2002. Evidence for a perforin-
mediated mechanism controlling cardiac inflammation in Try-
panosoma cruzi infection. Int J Exp Pathol 83: 67-79.
Higuchi M de L, Benvenuti LA, Martins Reis M, Metzger M 2003. 
Pathophysiology of the heart in Chagas’ disease: current status 
and new developments. Cardiovasc Res 60: 96-107.
Hoste EA, Kellun JA 2006. Acute kidney dysfunction and the criti-
cally ill. Minerva Anestesiol 7: 133-143.
Huber S, Shi C, Budd RC 2002. Gamma/delta T cells promote a Th1 
response during coxsackievirus B3 infection in vivo: role of Fas 
and Fas ligand. J Virol 76: 6487-6494.
 Kataoka T,  Budd RC,  Holler N,  Thome M,  Martinon F,  Irmler M, 
Burns K, Hahne M,  Kennedy N,  Kovacsovics M,  Tschopp J 
2000. The caspase-8 inhibitor FLIP promotes activation of NF-
kappaB and Erk signaling pathways. Curr Biol 10: 640-648. 
Lambert C, Landau AM, Desbarats J 2003. Fas-beyond death: a 
regenerative role for Fas in the nervous system. Apoptosis 
8: 551-562.
Leon JS, Wang K, Engman DM 2003. Captopril ameliorates myo-
carditis in acute experimental Chagas disease. Circulation 107: 
2264-2269.
Linjnem PJ, Petrov VV 2003. Role of intracardiac renin-angiotensin-
aldosterone system in extracellular matrix remodeling. Methods 
Find Exp Clin Pharmacol 25: 541-564.
Lopes MF, Nunes MP, Henriques-Pons A, Giese N, Morse HC 3rd 
Davidson WF, Araújo-Jorge TC, Dos Reis GA 1999. Increased 
susceptibility of Fas ligand-deficient gld mice to Trypanosoma 
cruzi infection due to a Th2-biased host immune response. Eur 
J Immunol 29: 81-89.
Martins GA, Petkova SB, Machado FS, Kitsis RN, Weiss LM, Wintner 
RM, Tanowitz HB, Silva JS 2001. Fas-FasL interaction modulates 
nitric oxide production in Trypanosoma cruzi-infected mice. Im-
munology 103: 122-129.
Martins GA, Vieira LQ, Cunha FQ, Silva JS 1999. Gamma interferon 
modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and 
nitric oxide-induced apoptosis during the acute phase of Try-
panosoma cruzi infection: a possible role in immune response 
control. Infect Immun 67: 3864-3871.
Mitchell GF, Jeron A, Koren G 1998. Measurement of heart rate and 
Q-T interval in the unscious mouse. Am J Physiol 274 (3 Pt 2): 
H747-751.
Moncayo A 2003. Chagas disease: current epidemiological trends 
after the interruption of vectorial and transfusional transmis-
sion in the Southern Cone countries. Mem Inst Oswaldo Cruz 
98: 577-591.
Nelson RW, Couto CG 1992. Essentials of small animal internal med-
icine, Mosby-Year Book Inc, New York, 32 pp.
Palazzuoli A, Gallotta M, Iovine F, Nuti R, Silverberg DS 2008. 
Anaemia in heart failure: a common interaction with renal in-
sufficiency called the cardio-renal anaemia syndrome. Int J Clin 
Pract 62: 281-286.
Schelling JR, Cleveland RP 1999. Involvement of Fas-dependent 
apoptosis in renal tubular epithelial cell deletion in chronic renal 
failure. Kidney Int 56: 1313-1316.
Seko Y, Kayagaki N, Seino K, Yagita H, Okumura K, Nagai R 2002. 
Role of Fas/FasL pathway in the activation of infiltrating cells 
in murine acute myocarditis caused by Coxsackievirus B3. J Am 
Coll Cardiol 39: 1399-1403.
Silverberg DS, Wexler D, Blum M, Wollman Y, Iaina A 2003. The 
cardio-renal anemia syndrome: does it exist? Nephrol Dial Trans-
plant 18 (Suppl. 8): 7-12.
Silverberg DS, Wexler D, Blum M, Wollman Y, Iaina A 2004. The 
association between congestive heart failure and chronic renal 
disease. Curr Opin Nephrol Hypertens 13: 163-170.
Silverberg DS, Wexler D, Blum M, Wollman Y, Iaina A, Sheps D, 
Keren G, Scwartz D 2005. Erythropoietin in heart failure. Semin 
Nephrol 25: 397-403.
Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozakis S, Nakao K, 
Nagata S 1995. Expression of the Fas ligand in cells of T cell 
lineage. J Immunol 154: 3806-3813.
Thadhani R, Pascual M, Boneventre JV 1996. Acute renal failure. 
N Engl J Med 334: 1448-1460.
Thome M, Tschopp J 2001. Regulation of lymphocyte proliferation 
and death by FLIP. Nat Rev Immunol 1: 50-58.
WHO - World Health Organization 2004. [homepage on the internet] 
[up date 2004 May 2; cited 2006 June 19]. TDR summary report 
2004-2005. Avaliable from http://www.who.int/tdr/publications/
tdrnews/default.htm.
Yoshida N 2009. Molecular mechanisms of Trypanosoma cruzi in-
fection by oral route. Mem Inst Oswaldo Cruz 104 (Suppl. 1): 
101-107.
